论文部分内容阅读
缺血性脑血管病（ICVD）为老年常见疾病，选用合适的药物改善病人的异常血液流变学状态，对预防及治疗脑血栓形成非常重要。东菱精纯克栓酶（DF—521）注射液为新型强力溶血栓改善微循环制剂，它除具有分解纤维蛋白原，抑制血栓形成[1.2]，诱发组织血浆素原活化素（t-PA）的释
Ischemic cerebrovascular disease (ICVD) is a common disease in the elderly, the choice of appropriate drugs to improve the patient’s abnormal hemorheological status, prevention and treatment of cerebral thrombosis is very important. DF-521 injection is a new powerful thrombolytic agent to improve microcirculation. It not only has the ability of decomposing fibrinogen and inhibiting thrombosis [1.2], but also induces tissue plasminogen activator (t-PA ) Release